Crinetics Pharmaceuticals (CRNX) Leases: 2019-2025
Historic Leases for Crinetics Pharmaceuticals (CRNX) over the last 7 years, with Sep 2025 value amounting to $41.1 million.
- Crinetics Pharmaceuticals' Leases fell 7.05% to $41.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $41.1 million, marking a year-over-year decrease of 7.05%. This contributed to the annual value of $43.5 million for FY2024, which is 6.54% down from last year.
- Per Crinetics Pharmaceuticals' latest filing, its Leases stood at $41.1 million for Q3 2025, which was down 1.80% from $41.9 million recorded in Q2 2025.
- Over the past 5 years, Crinetics Pharmaceuticals' Leases peaked at $48.0 million during Q3 2023, and registered a low of $1.3 million during Q2 2023.
- For the 3-year period, Crinetics Pharmaceuticals' Leases averaged around $36.5 million, with its median value being $43.5 million (2024).
- As far as peak fluctuations go, Crinetics Pharmaceuticals' Leases fell by 26.16% in 2023, and later soared by 3,492.18% in 2024.
- Quarterly analysis of 5 years shows Crinetics Pharmaceuticals' Leases stood at $1.9 million in 2021, then dropped by 21.46% to $1.5 million in 2022, then spiked by 3,032.50% to $46.5 million in 2023, then declined by 6.54% to $43.5 million in 2024, then declined by 7.05% to $41.1 million in 2025.
- Its last three reported values are $41.1 million in Q3 2025, $41.9 million for Q2 2025, and $42.7 million during Q1 2025.